A detailed history of Contravisory Investment Management, Inc. transactions in Vericel Corp stock. As of the latest transaction made, Contravisory Investment Management, Inc. holds 4,538 shares of VCEL stock, worth $257,259. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,538
Previous 4,538 -0.0%
Holding current value
$257,259
Previous $208,000 8.17%
% of portfolio
0.04%
Previous 0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$41.71 - $52.9 $189,279 - $240,060
4,538 New
4,538 $208,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Contravisory Investment Management, Inc. Portfolio

Follow Contravisory Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Contravisory Investment Management, Inc. with notifications on news.